[HTML][HTML] Steroid hyperglycemia: prevalence, early detection and therapeutic recommendations: a narrative review

HE Tamez-Pérez, DL Quintanilla-Flores… - World journal of …, 2015 - ncbi.nlm.nih.gov
Steroids are drugs that have been used extensively in a variety of conditions. Although
widely prescribed for their anti-inflammatory and immunosuppressive properties …

[PDF][PDF] Glucocorticoid-induced diabetes and adrenal suppression: how to detect and manage them

DP leigHanne KraMer HustaK… - Cleveland Clinic Journal …, 2011 - cdn.mdedge.com
Glucocorticoids, commonly used to treat multiple inflammatory processes, can cause
hyperglycemia, Cushing syndrome, adrenal suppression, and, when they are discontinued …

Hyperglycemia related to high-dose glucocorticoid use in noncritically ill patients

JG Gonzalez-Gonzalez, LG Mireles-Zavala… - Diabetology & metabolic …, 2013 - Springer
Background Glucocorticoids commonly cause drug-induced diabetes. This association is
well recognized but available evidence does not answer clinically relevant issues in …

Analysis of Glucocorticoid-Related Genes Reveal CCHCR1 as a New Candidate Gene for Type 2 Diabetes

LN Brenner, JM Mercader, CC Robertson… - Journal of the …, 2020 - academic.oup.com
Glucocorticoids have multiple therapeutic benefits and are used both for
immunosuppression and treatment purposes. Notwithstanding their benefits, glucocorticoid …

[HTML][HTML] Effect of inhaled corticosteroids on glycemic status

F Egbuonu, FA Antonio, M Edavalath - The open respiratory …, 2014 - ncbi.nlm.nih.gov
Although the dysglycemic effects of systemic glucocorticoid therapy are well known, the
effect of inhaled corticosteroids (ICS) on carbohydrate metabolism is still a subject of debate …

Glucocorticoid-induced hyperglycemia and diabetes: practical points

M Descours, V Rigalleau - Annales d'Endocrinologie, 2023 - Elsevier
Glucocorticoids are widely used in medical practice for their anti-inflammatory action, but
lead to hyperglycemia in 30% of cases, due to rapid reduction of insulin secretion and …

[HTML][HTML] Pentoxifylline versus steroid therapy for idiopathic sudden sensorineural hearing loss with diabetes

WC Lan, CY Wang, CD Lin - The Journal of International Advanced …, 2018 - ncbi.nlm.nih.gov
OBJECTIVES To compare the efficacy of pentoxifylline with that of conventional steroid
therapy in diabetic patients with idiopathic sudden sensorineural hearing loss (ISSNHL) and …

Do benefits outweigh risks for corticosteroid therapy in acute exacerbation of chronic obstructive pulmonary disease in people with diabetes mellitus?

AM Aldibbiat, A Al-Sharefi - International Journal of Chronic …, 2020 - Taylor & Francis
Chronic obstructive pulmonary disease (COPD) and diabetes mellitus (DM) are chronic
health conditions with significant impacts on quality and extent of life. People with COPD …

Optimal initial insulin dosage for managing steroid-induced hyperglycemia in hospitalized COVID-19 patients: A retrospective single-center study

N Ketaroonrut, S Kiertiburanakul… - SAGE Open …, 2024 - journals.sagepub.com
Objectives: To determine the optimal initial insulin dosage for controlling hyperglycemia in
COVID-19 patients receiving steroids, an area with limited data. Methods: We retrospectively …

Sudden sensorineural hearing loss: systemic steroid therapy and the risk of glucocorticoid-induced hyperglycemia

C Rohrmeier, N Koemm, P Babilas, P Prahs… - European Archives of …, 2013 - Springer
Sudden sensorineural hearing loss is usually treated with systemic glucocorticoids.
Intratympanic injections of glucocorticoids offer a possibly equivalent treatment alternative …